Saturday, 31 May 2014

Roche immunotherapy drug shrinks tumors in early bladder cancer study

ZURICH (Reuters) - Roche's experimental drug that spurs the immune system to fight cancer shrank tumors in 43 percent of people with a specific type of metastatic bladder cancer, according to results of an early-stage trial published on Saturday.
































via Reuters: Health News Read More Here..


Lake forest health and fitness http://ift.tt/T1lYUj

Experimental Drug May Extend Lung Cancer Survival, Study Suggests

But experts debate significance of this expensive treatment via Resurrection Health Care - Daily News More READ


Lake forest health and fitness http://ift.tt/1rtCMSZ

New Drug Shows Promise for Resistant Thyroid Cancer

Lenvatinib shrunk tumors in 65 percent of those taking the drug, according to late-stage research via Resurrection Health Care - Daily News More READ


Lake forest health and fitness http://ift.tt/1rtCKe0

Pair of Pills Shows Promise for Recurrent Ovarian Cancer

Preliminary findings suggest this experimental treatment might slow disease via Resurrection Health Care - Daily News More READ


Lake forest health and fitness http://ift.tt/1rtCM5D

Drug helps breast cancer patients keep fertility


In this May 29, 2014 photo, Christy Wolford, a breast cancer survivor, holds her youngest son Lucas, 2, as her other children Lauren, 8, Alexander, 4, and Everett, 3, play on the swing in the background at her Primrose School in Fort Collins, Colo. Young women with breast cancer might be able to avoid infertility caused by chemotherapy if they use a drug to shut down their ovaries temporarily, while treatment goes on. Wolford's ovaries were suppressed during cancer treatment and she has had three boys since it ended in 2006. (AP Photo/Ed Andrieski) CHICAGO (AP) — Doctors may have found a way to help young breast cancer patients avoid infertility caused by chemotherapy. Giving a drug to shut down the ovaries temporarily seems to boost the odds they will work after treatment ends, and it might even improve survival, a study found.








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1tx122s

Roche immunotherapy drug shrinks tumors in early bladder cancer study


Logo of Swiss pharmaceutical company Roche is seen at a plant in Rotkreuz Roche's experimental drug that spurs the immune system to fight cancer shrank tumors in 43 percent of people with a specific type of metastatic bladder cancer, according to results of an early-stage trial published on Saturday. The drug MPDL3280A is part of a closely-watched class of treatments known as anti-PDL1 therapies, which work by blocking a tumor's ability to evade the immune system's defense. Data from the Phase I trial presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago found MPDL3280A shrank tumors in 13 out of 30 patients who had been previously treated for metastatic urothelial bladder cancer. "It’s exciting to see a potential new treatment for bladder cancer patients who have been waiting a long time for new therapies," said Peter Johnson, chief clinician at Cancer Research UK whose experimental cancer medicine center was used in the trial.








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1rtCJ9X

How Simple Illusions Can Alter Our Perception Of The World Around Us


How Simple Illusions Can Alter Our Perception Of The World Around Us We're familiar with the mind games and tricks magicians use on a daily basis -- but what if we can take those "hacks" and apply them to our own perceptions? In the Brainwave clip above, sleight-of-hand specialist Apollo Robbins explains that while it's their job as artists to deceive the mind, we can also tap into this wisdom in order to focus on the important imagery around us. This ability to tap into human behavior, Apollo explains, can open up a world of insight. "When you look at all this massive data that comes in from our senses, and it








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1tx11vw

32 Things I Know Are True on My 32nd Birthday


32 Things I Know Are True on My 32nd Birthday I felt so adult in my mid 20s, which I'm grateful for because I'm sure it propelled me to where I am today. But at 32, I can wholeheartedly say I feel much freer and younger in mind, body and spirit.








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1tx0YQ6

The 9 Foods You Should Be Eating For Your Skin This Summer


The 9 Foods You Should Be Eating For Your Skin This Summer Memorial Day weekend brought barbecues, picnics and beach parties, which means that despite summer's official start on June 21, the season is already underway for many of us. But before you toss back more hot dogs, chips or beer, think about how it might affect how you look and feel -- and no, we don't mean your waistline. "It's not just the sun that can age your skin," Paula Simpson, a biochemist and holistic nutritionist who specializes in supplement formulation for skin health, told HuffPost. "Diet influences skin at the cellular level, and since skin is our largest organ, it's








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1jHdDdY

6 Vegan Habits Everyone Should Adopt (Without Giving Up Meat)


6 Vegan Habits Everyone Should Adopt (Without Giving Up Meat) By Brianna Steinhilber For meat-lovers, "vegan" may be a dirty five-letter-word -- but we all have to admit that those following a vegan diet tend to have a smart approach to eating, filling their carts with fresh produce and possessing a strong awareness of what they're putting on their plates. While the diet may be too extreme for many, there are some sensible, healthy vegan habits that we all should be copying –- carnivores included. Leave the meat on your plate, but take these six other veg-friendly tips to heart. 1. Pile on the veggies. Since vegans steer clear of








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1jHdDdH

Eli Lilly drug prolongs survival in large lung cancer trial

(Reuters) - Eli Lilly and Co's cancer drug ramucirumab modestly extended survival in a large, late-stage study of patients with advanced, nonsmall cell lung cancer who had relapsed following initial treatment, according to data presented on Saturday.
































via Reuters: Health News Read More Here..


Lake forest health and fitness http://ift.tt/1nOUrR5

Obama's boldest move on carbon comes with perils


FILE - This May 5, 2014 file photo shows a pickup truck driving down a road of the Homer City Generating Station in Homer City, Pa. The Obama administration is poised to unveil first-ever rules limiting greenhouse gas emissions from the power plants that dot the U.S. map. President Barack Obama says the rules are essential to curb climate change, but critics disagree. (AP Photo/Keith Srakocic, File) WASHINGTON (AP) — The new pollution rule the Obama administration announces Monday will be a cornerstone of President Barack Obama's environmental legacy and arguably the most significant U.S. environmental regulation in decades.








via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1oc7p9T

New Study Uncovers Clues to the Genetic Cause of Schizophrenia

Number and nature of mutations influence an individual's risk of developing schizophrenia, finds new study published in Neuron. The findings could have important implications for the early detection and treatment of schizophrenia. Maria Karayiorgou, MD, professor of psychiatry and Joseph Gogos, MD, PhD, professor of physiology and cellular biophysics and of neuroscience, and their team sequenced the "exome"-the region of the human genome that codes for proteins-of ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1oUvPGb

Eli Lilly drug prolongs survival in large lung cancer trial

Eli Lilly and Co's cancer drug ramucirumab modestly extended survival in a large, late-stage study of patients with advanced, nonsmall cell lung cancer who had relapsed following initial treatment, according to data presented on Saturday. In the 1,253-patient trial, those who received ramucirumab and the common chemotherapy drug docetaxel on average lived for 10.5 months compared with 9.1 months for those who got only the chemotherapy. While the difference amounts to only about six weeks, it was deemed by researchers to be statistically significant and clinically meaningful due to the extremely poor survival prognosis for advanced lung cancer that comes back following initial treatment. "This is the first treatment in approximately a decade to improve the outcome of patients" whose cancer has returned, Dr. Maurice Perol, the study's lead investigator and head of thoracic oncology at Cancer Research Center of Lyon in France, said in a statement. via Health News Headlines - Yahoo News Read More Here..


Lake forest health and fitness http://ift.tt/1twLmME

Two experimental AstraZeneca drugs show promise in ovarian cancer

(Reuters) - A combination of two drugs developed by AstraZeneca Plc, olaparib and cediranib, was shown in a mid-stage study to nearly double the length of time certain ovarian cancer patients lived without their disease getting worse.






via Reuters: Health News Read More Here..


Lake forest health and fitness http://ift.tt/1wFzDzL